Connect with us

ProSom (estazolam)


Estazolam (or ProSom®) is mainly prescribed to treat sleep disorders.

Status: ACTIVE

Class: Benzodiazepine

FDA Approval: 1997

Dosage Forms: 1 mg, 2 mg

Biological Half-life: 10-24 hours

Side Effects: Dizziness, sleepiness, hypokinesia, retrograde/anterograde amnesia, poor concentration, lack of coordination

Routes of Administration: Oral

Pregnancy Category: X (US)

 www.fda.gov

Advertisement

© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.